Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Non-cash Items (2021 - 2023)

Vistagen Therapeutics (VTGN) has disclosed Non-cash Items for 4 consecutive years, with $4800.0 as the latest value for Q1 2023.

  • Quarterly Non-cash Items fell 98.94% to $4800.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $4800.0 through Mar 2023, down 98.94% year-over-year, with the annual reading at $4800.0 for FY2023, 98.94% down from the prior year.
  • Non-cash Items hit $4800.0 in Q1 2023 for Vistagen Therapeutics, down from $452309.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $10.7 million in Q1 2021 to a low of $4800.0 in Q1 2023.
  • Historically, Non-cash Items has averaged $3.7 million across 3 years, with a median of $452309.0 in 2022.
  • Biggest five-year swings in Non-cash Items: crashed 95.79% in 2022 and later tumbled 98.94% in 2023.
  • Year by year, Non-cash Items stood at $10.7 million in 2021, then plummeted by 95.79% to $452309.0 in 2022, then crashed by 98.94% to $4800.0 in 2023.
  • Business Quant data shows Non-cash Items for VTGN at $4800.0 in Q1 2023, $452309.0 in Q1 2022, and $10.7 million in Q1 2021.